Reports: Daily Process, VAE, NHSN
description
Transcript of Reports: Daily Process, VAE, NHSN
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011
Reports: Daily Process, VAE, NHSN
Armstrong Institute for Patient Safety and Quality
Presented by: Kathleen Speck, MPHLinda Greene, RN, MPS, CIC
Armstrong Institute for Patient Safety and Quality2
Armstrong Institute for Patient Safety and Quality3
Armstrong Institute for Patient Safety and Quality4
Armstrong Institute for Patient Safety and Quality5
Armstrong Institute for Patient Safety and Quality6
Armstrong Institute for Patient Safety and Quality7
Armstrong Institute for Patient Safety and Quality8
Armstrong Institute for Patient Safety and Quality9
Armstrong Institute for Patient Safety and Quality10
Armstrong Institute for Patient Safety and Quality11
Armstrong Institute for Patient Safety and Quality12
Armstrong Institute for Patient Safety and Quality13
Armstrong Institute for Patient Safety and Quality14
Armstrong Institute for Patient Safety and Quality15
Armstrong Institute for Patient Safety and Quality16
Armstrong Institute for Patient Safety and Quality17
Armstrong Institute for Patient Safety and Quality18
Armstrong Institute for Patient Safety and Quality19
Armstrong Institute for Patient Safety and Quality20
Armstrong Institute for Patient Safety and Quality21
Armstrong Institute for Patient Safety and Quality22
Armstrong Institute for Patient Safety and Quality23
Armstrong Institute for Patient Safety and Quality24
What’s with this VAE
Stuff?I don’t get it. Lots of
mumbo- jumbo if you ask me
Surveillance Definition Change - VAP to VAE
http://www.cdc.gov/nhsn/VAE-calculator
NHSN Data
27
Total VAE
VAC Only
IVAC
Possible VAP
Probable VAP
We have the VAE data; now what?
• Comparative Data from NHSN• Other Changes ( Combine Possible and
Probable VAP)• Device Utilization Ratios
In the Meantime
29
Review Outcome Data
At the Bedside In Team Meetings
Patient Data
30
Vent Day
PEEP min
FiO2 Temp WBC Anti-microagent
Microsource
Polys Epis Organism
1 10 50 37.5 11.6 none
2 5 50 37.8 11.8 none
3 5 50 37.8 12.0 none ETA 3+ 0 s.aureus
4 8 70 38.2 15.0 PIPTAZVanco
5 8 60 38.5 14.2 PIPTAZVanco
6 6 50 38.0 12.9 PIPTAZVanco
7 5 40 37.5 11.8 PIPTAZVanco
8 5 40 37.6 11.6 none ETA 1+ 1+ Oral flora
Looking at the data
31
My first quarter VAC is 15.38 per 1,000 vent days
The average performance of the group is 5.5 per 1,000 vent days
Do I have opportunities?
Looking Carefully at the Measures
I notice that my SAT and SBT compliance is much lower than the cohort group.
I also notice that subglottic suctioning is lower than the peer group .
32
Looking at Cases
• Ms. X is a 26 y.o. vent dependent patient . She has a history anoxic brain injury and is admitted with pneumonia from a long term care facility ( LTCF)
• She is placed on antibiotics and after 4 days has stabilized on the vent. She is improving clinically and the plan is to return to the LTCF
• On day 7 , she has a significant event and a sustained period of worsening oxygenation.
• She meets definition for VAE
Case Review
• The clinicians have identified that her event was caused by a mucus plug.
• What Next?
The Analysis
Changes in Nurses and Respiratory Therapy staff- no documentation of secretions
Failure to notice thickened secretions and change in color of secretions
Although Patient was at baseline – did not get her up into a chair
Patient was dehydrated
Opportunities
• Hardwire ambulation protocols• Assure documentation of secretions• Work collaboratively with respiratory therapy to
identify subtle changes• Daily huddle
Another Case
Mrs. X is a 76 y.o woman admitted to the ICU with septic shock requiring large volume fluid resuscitation.
She is intubated and placed on the ventilator
She is stable on the ventilator until day 6 when she has progressing oxygenation demands
She has developed a VAC
Case evaluation
• No fever• No increased white count• No new antibiotics
Diagnosis: Pulmonary Edema Opportunities for improvement ?
Analysis
In another ICU, a large proportion of VAC’s are possible or probable pneumonia
Evaluation: HOB monitoring? Suctioning frequency? SATs? ET tubes with Subglottic suctioning?
41
Tools
The Change Model
“If we could change ourselves, the tendencies in the world would also change. As a man changes
his own nature, so does the attitude of the world change towards him. … We need not wait
to see what others do”
-Gandhi
43
Conclusion
Analyzing both process and outcome data will lead to new opportunities for improvement
VAE gives us an opportunity to take a broader view of patient safety.
It’s not about the numbers, it’s about the Patient
45
Next Steps for CUSP Conduct a culture assessment (HSOPS) Establish an interdisciplinary CUSP team Partner with a Senior Executive Review the Science of Safety training Identify defects Download results from your culture assessment (HSOPS) and share with
team Meet regularly with your CUSP team Use the Daily Goals tool in your ICU
46
Next Steps for Data Collection Unit Lead completes Structural Assessment Unit staff complete HSOPS Unit Lead/Data Facilitator enters Daily Process Measures Unit staff complete Exposure Receipt Assessment via survey link Unit Lead/Data Facilitator enters monthly VAE rates Unit Lead/Data Facilitator enters Early Mobility Measures Data Facilitator contemplates next steps for collecting Objective Outcomes
Measures Unit Lead/Data Facilitator pulls data reports from the data portal and
share the feedback with your frontline staff One person from unit (we recommend the Unit Lead) complete the
Implementation Assessment.